Plants get a GMO glow-up
As any avid gardener will tell you, plants with sharp thorns and prickles can leave you looking like you’ve had a run-in with an angry cat. Wouldn’t it be nice to rid plants of their prickles entirely but keep the tasty fruits and beautiful flowers?
who, along with my colleagues, recently across a variety of plants, including roses, eggplants and even some species of grasses. Genetically tailored, smooth-stemmed plants may eventually arrive at a garden center near you.
Acceleration of nature
Plants and other organisms evolve naturally over time. When random changes to their DNA, called mutations, enhance survival, they get passed on to offspring. , plant breeders have taken advantage of these variations to create high-yielding crop varieties.
In 1983, the , or GMOs, appeared in agriculture. , engineered to combat vitamin A deficiency, and are just a couple of examples of how genetic modification has been used to enhance crop plants.
Two recent developments have changed the landscape further. The advent of gene editing using a technique known as has made it possible to modify plant traits more easily and quickly. If the genome of an organism were a book, CRISPR-based gene editing is akin to adding or removing a sentence here or there.
This tool, combined with the increasing ease with which scientists can sequence an organism’s complete collection of DNA – or genome – is rapidly accelerating the ability to predictably engineer an organism’s traits.
By , our team was able to use gene editing to mutate the same gene in other prickly species, yielding smooth, prickle-free plants. In addition to eggplants, we got rid of prickles in a desert-adapted wild plant species with edible raisin-like fruits.
We also used a virus to silence the expression of a closely related gene in roses, yielding a rose without thorns.
In natural settings, prickles defend plants against grazing herbivores. But under cultivation, edited plants would be – and after harvest, fruit damage would be reduced. It’s worth noting that prickle-free plants still retain other defenses, such as their that deter insect pests.
From glowing petunias to purple tomatoes
Today, DNA modification technologies are no longer confined to large-scale agribusiness – they are becoming available directly to consumers.
One approach is to mutate certain genes, like we did with our prickle-free plants. For example, scientists have created a by inactivating the genes responsible for bitterness. Silencing the genes that delay flowering in tomatoes has resulted in well suited to urban agriculture.
Another modification approach is to permanently transfer genes from one species to another, using recombinant DNA technology to yield what scientists call a transgenic organism.
At a recent party, I found myself crowded into a darkened bathroom to observe the faint glow of the host’s newly acquired , which contains the genes responsible for the ghost ear mushroom’s bioluminescent glow. Scientists have also modified a pothos houseplant with a gene from rabbits, which allows it to that promote the breakdown of .
Consumers can also grow the , genetically engineered to contain pigment-producing genes from the snapdragon plant, resulting in antioxidant-rich tomatoes with a dark purple hue.
Risks and rewards
The introduction of genetically modified plants into the consumer market brings with it both exciting opportunities and potential challenges.
With genetically edited plants in the hands of the public, there could be less oversight over what people do with them. For instance, there is a risk of environmental release, which could have . Additionally, as the market for these plants expands, the quality of products may become more variable, necessitating new or more vigilant consumer protection laws. Companies could also apply patent rules limiting seed reuse, echoing some of the .
The future of plant genetic technology is bright – in some cases, quite literally. Bioluminescent golf courses, houseplants that emit tailored fragrances or flowers capable of changing their color in response to spray-based treatments are all theoretical possibilities. But as with any powerful technology, careful regulation and oversight will be crucial to ensuring these innovations benefit consumers while minimizing potential risks.
This article is republished from under a Creative Commons license. Read the .
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.